Phase 2a randomized clinical trial of dupilumab (anti-IL-4Ralpha) for alopecia areata patients. Guttman-Yassky E, Renert-Yuval Y, Bares J, Chima M, et al. Allergy 2022;77:897-906.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guttman-Yassky E, Renert-Yuval Y, Bares J, Chima M, et al. Phase 2a randomized clinical trial of dupilumab (anti-IL-4Ralpha) for alopecia areata patients. Allergy 2022;77:897-906.
PMID: 34460948